Developer docs
API playgroundTry for free, no card

Search company profiles

KEY-OBS

Full company profile

uuid02m2jdi

Namestring
KEY-OBS
Legal namestring
Société KEY OBS
Websiteurl
key-obs.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

KEY-OBS (legal entity: Société KEY OBS, Siret 430 234 799 00038) is a privately held French Contract Research Organization (CRO) founded in 2000 by Jean-Charles Bizot, PhD, and Fabrice Trovero, PhD, specializing exclusively in preclinical central nervous system (CNS) research. The company operates from a single facility at 13 Avenue Buffon in Orléans, France, approximately one hour from Paris, and is staffed by 1–10 employees. KEY-OBS serves pharmaceutical and biotechnology companies that require validated in vivo models and behavioral pharmacology expertise to support drug discovery programs targeting neurological and psychiatric indications including ADHD, anxiety, depression, schizophrenia, autism, Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease.

The company's core service portfolio comprises Pharmacological Studies using validated animal models tested with reference drugs, Behavioral Phenotyping of transgenic and inbred mouse strains (supported by an internal database of behavioral performance built over 24 years), Custom Designed Research projects, and CNS Test Services covering psychiatric, neurodegenerative, and neurodevelopmental indications. Specialized neuro-inflammation studies are delivered jointly with partner Artimmune, covering histology, immunohistochemistry, Western blot, rtPCR, and immunological analyses. Online study tracking enables clients to monitor progress in real time and adjust protocols collaboratively. Underlying technology is rooted in classical in vivo pharmacology and behavioral neuroscience rather than computational or AI-driven methods; proprietary assets are the validated model repertoire and the strain behavioral database.

KEY-OBS generates revenue through custom-priced, quote-based contract research engagements sold directly to enterprise pharmaceutical and biotechnology clients (B2B, sales-led motion). Pricing is not publicly disclosed and no revenue figure is available in the source material. The company has served more than 30 clients since founding, with most returning for repeat studies. Distribution is augmented through partnerships with ANS Biotech (pain pharmacology), Neuroservice (in vitro electrophysiology), and the NeuroServices Alliance global CRO network, alongside an academic collaboration with the École des Neurosciences de Paris-Ile de France (ENP). No external funding rounds, M&A activity, or parent-company relationships are disclosed; the company is fully owned and managed by its two founders.

Short descriptiontext

KEY-OBS is a French preclinical CRO founded in 2000 that provides behavioral phenotyping, validated in vivo animal models, and pharmacological studies in CNS and neuro-inflammation to pharmaceutical and biotechnology companies, operating from Orléans with 1–10 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOrléans, France
HQ citystring
Orléans
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical contract research, CNS pharmacology services, behavioral phenotyping services, neuroscience research services, in vivo animal models
Industry2 codes
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
Product category
Preclinical Contract Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Preclinical Contract Research Services
TypeProfessional Services
Description

Contract research services for pharmaceutical and biotechnology companies requiring preclinical studies, behavioral phenotyping, and pharmacological research in CNS field. Services are custom-designed and conducted collaboratively with client companies.

key-obs.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Key-Obs is a preclinical Contract Research Organization (CRO) that designs and runs in vivo pharmacology and behavioral phenotyping studies in rodents for pharmaceutical and biotechnology clients. Its offerings include validated animal models, a CNS test battery covering psychiatric, neurodegenerative and neurodevelopmental disorders, and custom-designed research protocols, all delivered from its laboratory facility in Orléans, France.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • More than 30 clients served since 2000, with most returning for new studies
+1 more record
Product overview1 text field

KEY-OBS is a preclinical Contract Research Organization (CRO) specializing in CNS (Central Nervous System) research for pharmaceutical and biotechnology companies. The company offers an integrated portfolio of services comprising Pharmacological Studies (validated animal models), Behavioral Phenotyping (functional evaluation of genomic mutations), Custom Designed Research (tailored to specific therapeutic areas), and Online Study Tracking. Additional specialized offerings include CNS Test Services covering psychiatric, neurodegenerative, and neurodevelopmental diseases, and Neuro-Inflammation Studies conducted in partnership with Artimmune. The services are designed for flexibility and collaborative protocol development with clients.

Product and service1 record
1Pharmacological Studies
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for in vivo services specifically in pain pharmacology research, complementing Key-Obs' CNS focus areas.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for in vitro safety and pharmacology services for CNS based on electrophysiological methods.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Key-Obs is a partner of the global pre-clinical CRO NeuroServices Alliance, a network of specialized CNS CROs offering complementary services worldwide.

4Ecole des Neurosciences de Paris-Ile de France (ENP)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration agreement signed for behavioral phenotyping of transgenic mice. Creates interface between basic research and use of specific strains in preclinical pharmacological studies, providing easy access to expertise and phenotyping services.

key-obs.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Combined collaboration to conduct preclinical studies on inflammation in brain diseases. Combines complementary know-how and technical skills covering histology, immunohistochemistry, biochemical analysis (WB, rtPCR), and immunological analysis for neurodegenerative diseases and psychiatric disorders.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

French preclinical CRO specializing in behavioral pharmacology and CNS efficacy/safety models. Direct comparable to Key-Obs given overlapping French base, founder-led operations, and similar focus on validated in vivo CNS models for pharma/biotech clients.

2Neurofit
TypeDirect peer
Description

French preclinical CRO specialized in in vitro CNS assays (MEA electrophysiology) for neurodegenerative and psychiatric drug discovery. Comparable specialty-CNS positioning and similar European boutique CRO profile.

TypeEmerging player
Description

UK-based preclinical CRO with growing CNS/neuroscience discovery and in vivo pharmacology capabilities for pharma/biotech. Specialty CRO of similar boutique scale to Key-Obs but with a broader discovery remit including medicinal chemistry and DMPK.

TypeBroad incumbent
Description

Global CRO/CDMO with significant preclinical and CNS-related pharmacology capacity. Competes for outsourced preclinical contracts from big pharma but offers vastly broader scale and integrated discovery-through-manufacturing services.

TypeBroad incumbent
Description

Large global CRO with a Discovery & Safety Assessment business that includes preclinical CNS in vivo services. Competes for the same biopharma buyer budgets but offers a much broader, multi-therapeutic-area portfolio and global footprint.

TypeDirect peer
Description

French CRO offering in vitro electrophysiology and safety pharmacology for CNS indications. Already an active partner of Key-Obs; directly comparable customer base and CNS therapeutic focus, with a complementary rather than overlapping in vitro toolkit.

7Labcorp (Covance)
TypeBroad incumbent
Description

Major global CRO/clinical lab with extensive preclinical capabilities spanning CNS and other therapeutic areas. Broad incumbent serving pharma/biotech across the full drug-development continuum with greater scale and geographic reach.

TypeDirect peer
Description

French-headquartered CRO offering preclinical and early clinical services including CNS/neurology models. Comparable to Key-Obs on geography, customer base (pharma/biotech), and CNS in vivo offering, though larger and more diversified.

TypeBroad incumbent
Description

Eurofins' discovery services arm offers preclinical and pharmacology services including CNS in vivo models for European pharma/biotech. Comparable customers and offering footprint, but operates as part of a much larger Eurofins Scientific platform.

TypeDirect peer
Description

US-based preclinical CRO specializing exclusively in CNS behavioral phenotyping and disease modeling for neurodegenerative and psychiatric disorders. Closest US analog to Key-Obs' deep CNS-only niche positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

KEY-OBS

Preclinical Contract Research Serviceskey-obs.com

KEY-OBS is a French preclinical CRO founded in 2000 that provides behavioral phenotyping, validated in vivo animal models, and pharmacological studies in CNS and neuro-inflammation to pharmaceutical and biotechnology companies, operating from Orléans with 1–10 employees.

What KEY-OBS does

KEY-OBS (legal entity: Société KEY OBS, Siret 430 234 799 00038) is a privately held French Contract Research Organization (CRO) founded in 2000 by Jean-Charles Bizot, PhD, and Fabrice Trovero, PhD, specializing exclusively in preclinical central nervous system (CNS) research. The company operates from a single facility at 13 Avenue Buffon in Orléans, France, approximately one hour from Paris, and is staffed by 1–10 employees. KEY-OBS serves pharmaceutical and biotechnology companies that require validated in vivo models and behavioral pharmacology expertise to support drug discovery programs targeting neurological and psychiatric indications including ADHD, anxiety, depression, schizophrenia, autism, Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease.

The company's core service portfolio comprises Pharmacological Studies using validated animal models tested with reference drugs, Behavioral Phenotyping of transgenic and inbred mouse strains (supported by an internal database of behavioral performance built over 24 years), Custom Designed Research projects, and CNS Test Services covering psychiatric, neurodegenerative, and neurodevelopmental indications. Specialized neuro-inflammation studies are delivered jointly with partner Artimmune, covering histology, immunohistochemistry, Western blot, rtPCR, and immunological analyses. Online study tracking enables clients to monitor progress in real time and adjust protocols collaboratively. Underlying technology is rooted in classical in vivo pharmacology and behavioral neuroscience rather than computational or AI-driven methods; proprietary assets are the validated model repertoire and the strain behavioral database.

KEY-OBS generates revenue through custom-priced, quote-based contract research engagements sold directly to enterprise pharmaceutical and biotechnology clients (B2B, sales-led motion). Pricing is not publicly disclosed and no revenue figure is available in the source material. The company has served more than 30 clients since founding, with most returning for repeat studies. Distribution is augmented through partnerships with ANS Biotech (pain pharmacology), Neuroservice (in vitro electrophysiology), and the NeuroServices Alliance global CRO network, alongside an academic collaboration with the École des Neurosciences de Paris-Ile de France (ENP). No external funding rounds, M&A activity, or parent-company relationships are disclosed; the company is fully owned and managed by its two founders.

KEY-OBS firmographics

Firmographics
Name
KEY-OBS
Legal name
Société KEY OBS
Website
https://key-obs.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
1–10 employees
Short description
KEY-OBS is a French preclinical CRO founded in 2000 that provides behavioral phenotyping, validated in vivo animal models, and pharmacological studies in CNS and neuro-inflammation to pharmaceutical and biotechnology companies, operating from Orléans with 1–10 employees.
Ownership category
akta.pro rank

KEY-OBS industry classification

Industry
Product category
Preclinical Contract Research Services
akta.pro industry
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Preclinical contract research
  • CNS pharmacology services
  • Behavioral phenotyping services
  • Neuroscience research services
  • In vivo animal models

Where KEY-OBS is headquartered

Location

Headquarters

HQ city
Orléans
HQ country
France
HQ region
Europe

Offices1 record

Markets served

KEY-OBS business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Preclinical Contract Research Services: Contract research services for pharmaceutical and biotechnology companies requiring preclinical studies, behavioral phenotyping, and pharmacological research in CNS field. Services are custom-designed and conducted collaboratively with client companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

KEY-OBS product offering

Product offering

Core offering

Key-Obs is a preclinical Contract Research Organization (CRO) that designs and runs in vivo pharmacology and behavioral phenotyping studies in rodents for pharmaceutical and biotechnology clients. Its offerings include validated animal models, a CNS test battery covering psychiatric, neurodegenerative and neurodevelopmental disorders, and custom-designed research protocols, all delivered from its laboratory facility in Orléans, France.

Product overview

KEY-OBS is a preclinical Contract Research Organization (CRO) specializing in CNS (Central Nervous System) research for pharmaceutical and biotechnology companies. The company offers an integrated portfolio of services comprising Pharmacological Studies (validated animal models), Behavioral Phenotyping (functional evaluation of genomic mutations), Custom Designed Research (tailored to specific therapeutic areas), and Online Study Tracking. Additional specialized offerings include CNS Test Services covering psychiatric, neurodegenerative, and neurodevelopmental diseases, and Neuro-Inflammation Studies conducted in partnership with Artimmune. The services are designed for flexibility and collaborative protocol development with clients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmacological Studies

Quantifiable outcome

  • More than 30 clients served since 2000, with most returning for new studies
  • +1 more outcomes

Companies that use KEY-OBS

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles1 record

KEY-OBS technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

KEY-OBS partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • ANS BiotechminorStrategic or Co-development PartnerPartnership for in vivo services specifically in pain pharmacology research, complementing Key-Obs' CNS focus areas.
  • NeuroserviceminorStrategic or Co-development PartnerPartnership for in vitro safety and pharmacology services for CNS based on electrophysiological methods.
  • NeuroServices AlliancecoreChannel Partner/ Reseller/ DistributorKey-Obs is a partner of the global pre-clinical CRO NeuroServices Alliance, a network of specialized CNS CROs offering complementary services worldwide.
  • Ecole des Neurosciences de Paris-Ile de France (ENP)coreStrategic or Co-development PartnerCollaboration agreement signed for behavioral phenotyping of transgenic mice. Creates interface between basic research and use of specific strains in preclinical pharmacological studies, providing easy access to expertise and phenotyping services.
  • ArtimmunecoreStrategic or Co-development PartnerCombined collaboration to conduct preclinical studies on inflammation in brain diseases. Combines complementary know-how and technical skills covering histology, immunohistochemistry, biochemical analysis (WB, rtPCR), and immunological analysis for neurodegenerative diseases and psychiatric disorders.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

KEY-OBS competitors and assessment

Company assessment

Direct peers

  • Porsolt: French preclinical CRO specializing in behavioral pharmacology and CNS efficacy/safety models. Direct comparable to Key-Obs given overlapping French base, founder-led operations, and similar focus on validated in vivo CNS models for pharma/biotech clients.
  • Neurofit: French preclinical CRO specialized in in vitro CNS assays (MEA electrophysiology) for neurodegenerative and psychiatric drug discovery. Comparable specialty-CNS positioning and similar European boutique CRO profile.
  • Neuroservice: French CRO offering in vitro electrophysiology and safety pharmacology for CNS indications. Already an active partner of Key-Obs; directly comparable customer base and CNS therapeutic focus, with a complementary rather than overlapping in vitro toolkit.
  • Biotrial: French-headquartered CRO offering preclinical and early clinical services including CNS/neurology models. Comparable to Key-Obs on geography, customer base (pharma/biotech), and CNS in vivo offering, though larger and more diversified.
  • PsychoGenics: US-based preclinical CRO specializing exclusively in CNS behavioral phenotyping and disease modeling for neurodegenerative and psychiatric disorders. Closest US analog to Key-Obs' deep CNS-only niche positioning.

Emerging players

  • Sygnature Discovery: UK-based preclinical CRO with growing CNS/neuroscience discovery and in vivo pharmacology capabilities for pharma/biotech. Specialty CRO of similar boutique scale to Key-Obs but with a broader discovery remit including medicinal chemistry and DMPK.

Broad incumbents

  • WuXi AppTec: Global CRO/CDMO with significant preclinical and CNS-related pharmacology capacity. Competes for outsourced preclinical contracts from big pharma but offers vastly broader scale and integrated discovery-through-manufacturing services.
  • Charles River Laboratories: Large global CRO with a Discovery & Safety Assessment business that includes preclinical CNS in vivo services. Competes for the same biopharma buyer budgets but offers a much broader, multi-therapeutic-area portfolio and global footprint.
  • Labcorp (Covance): Major global CRO/clinical lab with extensive preclinical capabilities spanning CNS and other therapeutic areas. Broad incumbent serving pharma/biotech across the full drug-development continuum with greater scale and geographic reach.
  • Eurofins Discovery: Eurofins' discovery services arm offers preclinical and pharmacology services including CNS in vivo models for European pharma/biotech. Comparable customers and offering footprint, but operates as part of a much larger Eurofins Scientific platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

KEY-OBS social profiles

Digital presence

KEY-OBS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KEY-OBS leadership team

Management profile

Number of profiles

Profiles2 records

KEY-OBS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KEY-OBS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KEY-OBS

What does KEY-OBS do?

Key-Obs is a preclinical Contract Research Organization (CRO) that designs and runs in vivo pharmacology and behavioral phenotyping studies in rodents for pharmaceutical and biotechnology clients. Its offerings include validated animal models, a CNS test battery covering psychiatric, neurodegenerative and neurodevelopmental disorders, and custom-designed research protocols, all delivered from its laboratory facility in Orléans, France.

Is KEY-OBS a public or private company?

KEY-OBS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was KEY-OBS founded?

KEY-OBS was founded in 2000. It employs 1 to 10 people.

Where is KEY-OBS based?

KEY-OBS is headquartered in Orléans, France, in the Europe region.

How does KEY-OBS make money?

One revenue line is on record: preclinical Contract Research Services.

Who are KEY-OBS's main competitors?

Direct peers on record are Porsolt, Neurofit, Neuroservice, Biotrial and PsychoGenics. Sygnature Discovery is listed as an emerging player. Broad incumbents are WuXi AppTec, Charles River Laboratories, Labcorp (Covance) and Eurofins Discovery.

Does KEY-OBS have an API?

No public API is recorded for KEY-OBS.

What industry is KEY-OBS in?

KEY-OBS's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales